1351 related articles for article (PubMed ID: 27091820)
1. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
[TBL] [Abstract][Full Text] [Related]
2. Do systematic reviews on pediatric topics need special methodological considerations?
Farid-Kapadia M; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
BMC Pediatr; 2017 Mar; 17(1):57. PubMed ID: 28260530
[TBL] [Abstract][Full Text] [Related]
3. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review.
Page MJ; Moher D
Syst Rev; 2017 Dec; 6(1):263. PubMed ID: 29258593
[TBL] [Abstract][Full Text] [Related]
4. Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported?-two systematic reviews.
Farid-Kapadia M; Joachim KC; Balasingham C; Clyburne-Sherin A; Offringa M
Syst Rev; 2017 Mar; 6(1):31. PubMed ID: 28260528
[TBL] [Abstract][Full Text] [Related]
5. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
7. AHRQ series on complex intervention systematic reviews-paper 7: PRISMA-CI elaboration and explanation.
Guise JM; Butler M; Chang C; Viswanathan M; Pigott T; Tugwell P;
J Clin Epidemiol; 2017 Oct; 90():51-58. PubMed ID: 28720513
[TBL] [Abstract][Full Text] [Related]
8. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
[TBL] [Abstract][Full Text] [Related]
9. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for reporting of systematic reviews and meta-analyses of diagnostic test accuracy: a systematic review.
McGrath TA; Alabousi M; Skidmore B; Korevaar DA; Bossuyt PMM; Moher D; Thombs B; McInnes MDF
Syst Rev; 2017 Oct; 6(1):194. PubMed ID: 29017574
[TBL] [Abstract][Full Text] [Related]
11. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
[TBL] [Abstract][Full Text] [Related]
12. Reporting and Methodological Quality of Systematic Reviews and Meta-Analyses of Nursing Interventions in Patients With Alzheimer's Disease: General Implications of the Findings.
Sun X; Zhou X; Zhang Y; Liu H
J Nurs Scholarsh; 2019 May; 51(3):308-316. PubMed ID: 30806019
[TBL] [Abstract][Full Text] [Related]
13. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
Sun X; Zhou X; Yu Y; Liu H
BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
[TBL] [Abstract][Full Text] [Related]
14. Endorsement of PRISMA statement and quality of systematic reviews and meta-analyses published in nursing journals: a cross-sectional study.
Tam WW; Lo KK; Khalechelvam P
BMJ Open; 2017 Feb; 7(2):e013905. PubMed ID: 28174224
[TBL] [Abstract][Full Text] [Related]
15. Protocol for CONSORT-SPI: an extension for social and psychological interventions.
Montgomery P; Grant S; Hopewell S; Macdonald G; Moher D; Michie S; Mayo-Wilson E
Implement Sci; 2013 Sep; 8():99. PubMed ID: 24004579
[TBL] [Abstract][Full Text] [Related]
16. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
[TBL] [Abstract][Full Text] [Related]
17. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
[TBL] [Abstract][Full Text] [Related]
18. Compliance of Systematic Reviews in Plastic Surgery With the PRISMA Statement.
Lee SY; Sagoo H; Whitehurst K; Wellstead G; Fowler AJ; Agha RA; Orgill D
JAMA Facial Plast Surg; 2016; 18(2):101-5. PubMed ID: 26719993
[TBL] [Abstract][Full Text] [Related]
19. Compliance of systematic reviews in ophthalmology with the PRISMA statement.
Lee SY; Sagoo H; Farwana R; Whitehurst K; Fowler A; Agha R
BMC Med Res Methodol; 2017 Dec; 17(1):178. PubMed ID: 29281981
[TBL] [Abstract][Full Text] [Related]
20. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
